This webinar examines the likely global influence of the EU's revision of its pharmaceutical legislation on medicines markets and patients in low- and middle-income countries. The webinar reveals the social mechanisms or pathways through which the EU achieves these global impacts through concrete examples of medicines for NCDs and infectious diseases from Latin America and abroad. Bringing together the expertise of academics, and policy actors from the Global South and North, this webinar sparks a conversation about the EU’s role in global access to a safe and affordable supply of innovative medicines.